Literature DB >> 9880286

Fortnightly review: drug treatment of epilepsy.

M Feely1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9880286      PMCID: PMC1114575          DOI: 10.1136/bmj.318.7176.106

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  13 in total

Review 1.  New antiepileptic drugs.

Authors:  M A Dichter; M J Brodie
Journal:  N Engl J Med       Date:  1996-06-13       Impact factor: 91.245

Review 2.  Lamotrigine versus other antiepileptic drugs: a star rating system is born.

Authors:  M J Brodie
Journal:  Epilepsia       Date:  1994       Impact factor: 5.864

3.  Prescribing of anti-epileptic drugs in the northern and Yorkshire region: 1992-1995.

Authors:  S J Roberts; M Feely; D N Bateman
Journal:  Seizure       Date:  1998-04       Impact factor: 3.184

4.  A multicentre study of vigabatrin for drug-resistant epilepsy.

Authors:  T R Browne; R H Mattson; J K Penry; D B Smith; D M Treiman; B J Wilder; E Ben-Menachem; R M Miketta; K M Sherry; G K Szabo
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

5.  Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study. The US Gabapentin Study Group No. 5.

Authors: 
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

6.  Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group.

Authors:  M J Brodie; A Richens; A W Yuen
Journal:  Lancet       Date:  1995-02-25       Impact factor: 79.321

7.  Impact of valproate and phenytoin on cognitive function in elderly patients: results of a single-blind randomized comparative study.

Authors:  I Craig; R Tallis
Journal:  Epilepsia       Date:  1994 Mar-Apr       Impact factor: 5.864

8.  Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy.

Authors:  M de Silva; B MacArdle; M McGowan; E Hughes; J Stewart; B G Neville; A L Johnson; E H Reynolds
Journal:  Lancet       Date:  1996-03-16       Impact factor: 79.321

9.  A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group.

Authors:  R H Mattson; J A Cramer; J F Collins
Journal:  N Engl J Med       Date:  1992-09-10       Impact factor: 91.245

10.  Intermittent clobazam for catamenial epilepsy: tolerance avoided.

Authors:  M Feely; J Gibson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-12       Impact factor: 10.154

View more
  7 in total

1.  Drugs for epilepsy have teratogenic risks.

Authors:  E M Rosser; L C Wilson
Journal:  BMJ       Date:  1999-05-08

2.  The importance of drug adverse effects compared with seizure control for people with epilepsy: a discrete choice experiment.

Authors:  Andrew Lloyd; Emma McIntosh; Martin Price
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 3.  Levetiracetam. A review of its adjunctive use in the management of partial onset seizures.

Authors:  M Dooley; G L Plosker
Journal:  Drugs       Date:  2000-10       Impact factor: 9.546

4.  Inhibition of neuronal Ca(2+) influx by gabapentin and subsequent reduction of neurotransmitter release from rat neocortical slices.

Authors:  K Fink; W Meder; D J Dooley; M Göthert
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

5.  Outpatient utilization of drugs acting on nervous system: a study from the Republic of Srpska, Bosnia & Herzegovina.

Authors:  Vanda Marković-Peković; Svjetlana Stoisavljević-Satara; Ranko Skrbić
Journal:  Eur J Clin Pharmacol       Date:  2009-10-09       Impact factor: 2.953

Review 6.  Topiramate: a review of its use in childhood epilepsy.

Authors:  D Ormrod; K McClellan
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.930

7.  Antiepileptic drugs prescription utilization behavior and direct costs of treatment in a national hospital of India.

Authors:  Ahsan Haroon; Manjari Tripathi; R Khanam; Divya Vohora
Journal:  Ann Indian Acad Neurol       Date:  2012-10       Impact factor: 1.383

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.